Experimental Neuro-Oncology III
Introducing an innovative and time-effective method to generate ex vivo patient-derived glioblastoma organoid models
Microglia-mediated dexamethasone effects on glioblastoma (GBM) outgrowth in a rat organotypic brain slice co-culture (OBSC) and the role of the CXCL2/CXCR2-axis
Glycation interferes with sialyltransferase expression of glioblastoma cell lines and leads to increased polysialylation
Inhibition of the protein tyrosine phosphatase PTP1B by the small molecule inhibitor Claramine inhibits the growth stimulation of EGF in glioblastoma cells via inhibition of the MAPK pathway
A novel PCR-based assay for the detection of IDH1 and TERT promoter hotspot mutations in cell-free DNA
DNA-methylation profiling is an effective asset for identification of tumors in suspected, yet immunohistochemically unspecifiable, neuro-oncological cases
The role of onco-metabolite (R-2-hydroxyglutarate) in the IDH mutant glioblastoma microenvironment
Nimodipine treatment protects Schwann cells and neuronal cells but not tumor cells from cisplatin-induced cell death